|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.341
|
|
|
cellular response to interleukin 4
|
GO:0071353 |
21 |
0.273
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.230
|
|
|
dna repair
|
GO:0006281 |
107 |
0.206
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.168
|
|
|
negative regulation of cell size
|
GO:0045792 |
3 |
0.147
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.144
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.144
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.135
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.135
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.121
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.119
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.119
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.117
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.115
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.108
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.107
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.106
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.101
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.098
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.098
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.089
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.083
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.083
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.078
|
|
|
cation transport
|
GO:0006812 |
399 |
0.078
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.073
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.068
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.065
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.059
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.058
|
|
|
hexose catabolic process
|
GO:0019320 |
3 |
0.058
|
|
|
lipid particle organization
|
GO:0034389 |
7 |
0.057
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.057
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.056
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.055
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.053
|
|
|
spindle assembly
|
GO:0051225 |
13 |
0.051
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.050
|
|
|
retina homeostasis
|
GO:0001895 |
23 |
0.048
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.047
|
|
|
wound healing
|
GO:0042060 |
157 |
0.047
|
|
|
nadph regeneration
|
GO:0006740 |
2 |
0.046
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.045
|
|
|
ear development
|
GO:0043583 |
200 |
0.044
|
|
|
transcription coupled nucleotide excision repair
|
GO:0006283 |
2 |
0.043
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.043
|
|
|
positive regulation of viral genome replication
|
GO:0045070 |
2 |
0.043
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.042
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.041
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.041
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.041
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.041
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.040
|
|
|
protein import
|
GO:0017038 |
101 |
0.039
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.039
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.038
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.038
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.038
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.036
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.036
|
|
|
protein depolymerization
|
GO:0051261 |
34 |
0.036
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.036
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.036
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.035
|
|
|
cranial nerve formation
|
GO:0021603 |
4 |
0.035
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.035
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.034
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.034
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.033
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.033
|
|
|
rna interference
|
GO:0016246 |
2 |
0.032
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.032
|
|
|
chronological cell aging
|
GO:0001300 |
1 |
0.032
|
|
|
spindle organization
|
GO:0007051 |
28 |
0.032
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.032
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.032
|
|
|
substantia nigra development
|
GO:0021762 |
2 |
0.031
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.031
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.029
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.029
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.029
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.029
|
|
|
viral process
|
GO:0016032 |
41 |
0.029
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.029
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.028
|
|
|
negative regulation of purine nucleotide catabolic process
|
GO:0033122 |
9 |
0.028
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.028
|
|
|
glucose catabolic process
|
GO:0006007 |
3 |
0.027
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.027
|
|
|
thermosensory behavior
|
GO:0040040 |
1 |
0.027
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.027
|
|
|
response to interleukin 4
|
GO:0070670 |
23 |
0.027
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.027
|
|
|
cytoskeleton dependent intracellular transport
|
GO:0030705 |
50 |
0.027
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.027
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.027
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.027
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.026
|
|
|
recombinational repair
|
GO:0000725 |
21 |
0.026
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.026
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.026
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.026
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.026
|
|
|
microtubule based transport
|
GO:0010970 |
50 |
0.026
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.025
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.025
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.025
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.025
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.025
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.025
|
|
|
dna hypermethylation
|
GO:0044026 |
3 |
0.025
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.024
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.024
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.024
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.024
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.024
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
52 |
0.024
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.024
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.024
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.024
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.024
|
|
|
intermediate filament bundle assembly
|
GO:0045110 |
3 |
0.024
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.024
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.023
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.023
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.023
|
|
|
positive regulation of intracellular protein transport
|
GO:0090316 |
42 |
0.023
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.023
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.023
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.023
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.023
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.022
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.022
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.022
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.022
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.022
|
|
|
peptidyl proline modification
|
GO:0018208 |
6 |
0.022
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.021
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.021
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.021
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.021
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.021
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.021
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.021
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.021
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.021
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.021
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.021
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.020
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.020
|
|
|
dna dealkylation
|
GO:0035510 |
11 |
0.020
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.020
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.020
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.020
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.020
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.020
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.020
|
|
|
coagulation
|
GO:0050817 |
78 |
0.020
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.020
|
|
|
skeletal myofibril assembly
|
GO:0014866 |
4 |
0.020
|
|
|
anion transport
|
GO:0006820 |
177 |
0.020
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.020
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.020
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.020
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.020
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.020
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.020
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.020
|
|
|
telomere maintenance via telomerase
|
GO:0007004 |
1 |
0.019
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.019
|
|
|
pentose phosphate shunt
|
GO:0006098 |
2 |
0.019
|
|
|
negative regulation of oxidative stress induced intrinsic apoptotic signaling pathway
|
GO:1902176 |
4 |
0.019
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.019
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.019
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.019
|
|
|
intrahepatic bile duct development
|
GO:0035622 |
2 |
0.019
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.018
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.018
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.018
|
|
|
dna modification
|
GO:0006304 |
50 |
0.018
|
|
|
photoreceptor cell development
|
GO:0042461 |
40 |
0.018
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.018
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.018
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.018
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.017
|
|
|
cellular protein complex disassembly
|
GO:0043624 |
36 |
0.017
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.017
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.017
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.017
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.017
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.017
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.017
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.017
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.017
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.017
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.017
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.017
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.016
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.016
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.016
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.016
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.016
|
|
|
negative regulation of chromatin silencing
|
GO:0031936 |
1 |
0.016
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.016
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.016
|
|
|
positive regulation of mrna metabolic process
|
GO:1903313 |
17 |
0.016
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.016
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.016
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.016
|
|
|
skeletal muscle thin filament assembly
|
GO:0030240 |
2 |
0.016
|
|
|
positive regulation of heart rate by epinephrine norepinephrine
|
GO:0001996 |
4 |
0.016
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.016
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.016
|
|
|
regulation of ubiquitin protein ligase activity involved in mitotic cell cycle
|
GO:0051439 |
1 |
0.015
|
|
|
kidney development
|
GO:0001822 |
213 |
0.015
|
|
|
dendritic spine morphogenesis
|
GO:0060997 |
22 |
0.015
|
|
|
placenta development
|
GO:0001890 |
140 |
0.015
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.015
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.015
|
|
|
regulation of immunological synapse formation
|
GO:2000520 |
2 |
0.015
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.015
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.015
|
|
|
cranial nerve morphogenesis
|
GO:0021602 |
26 |
0.015
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.015
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.015
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.015
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.015
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.015
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.015
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.015
|
|
|
positive regulation of protein export from nucleus
|
GO:0046827 |
4 |
0.015
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.015
|
|
|
tube formation
|
GO:0035148 |
140 |
0.015
|
|
|
coenzyme metabolic process
|
GO:0006732 |
52 |
0.015
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.015
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.015
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.015
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.014
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.014
|
|
|
nerve development
|
GO:0021675 |
67 |
0.014
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.014
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
52 |
0.014
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.014
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.014
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.014
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.014
|
|
|
regulation of transcription by chromatin organization
|
GO:0034401 |
0 |
0.014
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.014
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.014
|
|
|
viral life cycle
|
GO:0019058 |
36 |
0.014
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.014
|
|
|
cell cell recognition
|
GO:0009988 |
44 |
0.014
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.014
|
|
|
cranial nerve development
|
GO:0021545 |
41 |
0.014
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.014
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.014
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.014
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.014
|
|
|
vascular smooth muscle contraction
|
GO:0014829 |
5 |
0.014
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.014
|
|
|
synaptonemal complex organization
|
GO:0070193 |
15 |
0.014
|
|
|
positive regulation of actin filament depolymerization
|
GO:0030836 |
5 |
0.014
|
|
|
cilium morphogenesis
|
GO:0060271 |
102 |
0.013
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.013
|
|
|
cofactor biosynthetic process
|
GO:0051188 |
41 |
0.013
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.013
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.013
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.013
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.013
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.013
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.013
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.013
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.013
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.013
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.013
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.013
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.013
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.013
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.013
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.013
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.013
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
28 |
0.013
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.013
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.013
|
|
|
positive regulation of actin nucleation
|
GO:0051127 |
3 |
0.013
|
|
|
histone modification
|
GO:0016570 |
159 |
0.013
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.012
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.012
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.012
|
|
|
positive regulation of atpase activity
|
GO:0032781 |
3 |
0.012
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.012
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.012
|
|
|
rna dependent dna replication
|
GO:0006278 |
3 |
0.012
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.012
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.012
|
|
|
regulation of calcium ion transmembrane transport
|
GO:1903169 |
20 |
0.012
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.012
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.012
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.012
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.012
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.012
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.012
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.012
|
|
|
fertilization
|
GO:0009566 |
127 |
0.012
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.012
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.012
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.012
|
|
|
response to amine
|
GO:0014075 |
16 |
0.012
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.012
|
|
|
response to testosterone
|
GO:0033574 |
3 |
0.012
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.012
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.011
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.011
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.011
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.011
|
|
|
neural retina development
|
GO:0003407 |
41 |
0.011
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.011
|
|
|
positive regulation of cardiac muscle contraction
|
GO:0060452 |
2 |
0.011
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.011
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.011
|
|
|
dna replication
|
GO:0006260 |
52 |
0.011
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.011
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.011
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.011
|
|
|
skin development
|
GO:0043588 |
220 |
0.011
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.011
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.011
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.011
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.011
|
|
|
chromatin remodeling
|
GO:0006338 |
32 |
0.011
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.011
|
|
|
regulation of protein import into nucleus translocation
|
GO:0033158 |
2 |
0.011
|
|
|
negative regulation of intracellular transport
|
GO:0032387 |
38 |
0.011
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.011
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.011
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.011
|
|
|
positive regulation of rna splicing
|
GO:0033120 |
12 |
0.011
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.011
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.011
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.011
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.011
|
|
|
protein sumoylation
|
GO:0016925 |
14 |
0.011
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.011
|
|
|
positive regulation of viral process
|
GO:0048524 |
5 |
0.011
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.011
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.011
|
|
|
spindle assembly involved in female meiosis
|
GO:0007056 |
3 |
0.011
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.010
|
|
|
translesion synthesis
|
GO:0019985 |
1 |
0.010
|
|
|
optic nerve morphogenesis
|
GO:0021631 |
6 |
0.010
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.010
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.010
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.010
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.010
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.010
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.010
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.010
|
|
|
response to increased oxygen levels
|
GO:0036296 |
2 |
0.010
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.010
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.010
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.010
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.010
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.010
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.010
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.010
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.010
|
|